C. Viallard

Molecular Biology · 2017

A researcher in the Science corpus: 1 paper; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom C. Viallard trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. Peter Carmeliet
  3. G. Bergers
  4. S. Bray
  5. John M. L. Ebos
  6. Georgina N. Masoud
  7. P. Mattila
  8. A. Ridley
  9. N. Ferrara
  10. R. Kerbel

Papers from C. Viallard's perspective

Ordered by how strongly the researchers C. Viallard trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
  3. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
  4. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (Cancer Research)
  5. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
  6. Molecular mechanisms and clinical applications of angiogenesis (Nature)
  7. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. (Cancer Cell)
  8. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system (Nature reviews. Molecular cell biology)
  9. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. (Cell)
  10. The biology of VEGF and its receptors (Nature Medicine)

Their papers